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Abstract
Introduction An increasing body of evidence shows that the
tumour microenvironment is essential in driving neoplastic
progression. The low serum component of this
microenvironment stimulates motility/invasion in human breast
cancer cells via activation of the Na+–H+ exchanger (NHE)
isoform 1, but the signal transduction systems that underlie this
process are still poorly understood. We undertook the present
study to elucidate the role and pattern of regulation by the Rho
GTPases of this serum deprivation-dependent activation of both
NHE1 and subsequent invasive characteristics, such as
pseudopodia and invadiopodia protrusion, directed cell motility
and penetration of normal tissues.
Methods The present study was performed in a well
characterized human mammary epithelial cell line representing
late stage metastatic progression, MDA-MB-435. The activity of
RhoA and Rac1 was modified using their dominant negative and
constitutively active mutants and the activity of NHE1, cell
motility/invasion, F-actin content and cell shape were measured.
Results We show for the first time that serum deprivation
induces NHE1-dependent morphological and cytoskeletal
changes in metastatic cells via a reciprocal interaction of RhoA
and Rac1, resulting in increased chemotaxis and invasion.
Deprivation changed cell shape by reducing the amount of F-
actin and inducing the formation of leading edge pseudopodia.
Serum deprivation inhibited RhoA activity and stimulated Rac1
activity. Rac1 and RhoA were antagonistic regulators of both
basal and stimulated tumour cell NHE1 activity. The regulation
of NHE1 activity by RhoA and Rac1 in both conditions was
mediated by an alteration in intracellular proton affinity of the
exchanger. Interestingly, the role of each of these G-proteins
was reversed during serum deprivation; basal NHE1 activity was
regulated positively by RhoA and negatively by Rac1, whereas
RhoA negatively and Rac1 positively directed the stimulation of
NHE1 during serum deprivation. Importantly, the same pattern of
RhoA and Rac1 regulation found for NHE1 activity was
observed in both basal and serum deprivation dependent
increases in motility, invasion and actin cytoskeletal
organization.
Conclusion Our findings suggest that the reported antagonistic
roles of RhoA and Rac1 in cell motility/invasion and cytoskeletal
organization may be due, in part, to their concerted action on
NHE1 activity as a convergence point.
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Introduction
Tumour invasion and metastasis associated with neoplastic
progression are the major causes of cancer deaths. The
invasive process occurs through a complex series of inter-R616
ca = constitutively active; dn = dominant negative; DMA = 5-(N, N-dimethyl)-amiloride; DMEM = Dulbecco's modified Eagle's medium; GST = glu-
tathione S-transferase; HA = haemagglutinin; NHE = Na+/H+ exchanger; PAK = p21-activated kinase; PBS = phosphate-buffered saline; pHi = intra-
cellular pH; PI3K = phosphoinositide-3 kinase; RBD = Rho-binding domain of Rhotekin; ROCK = Rho kinase.
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R617actions with the host tissue, resulting in infiltration and pen-
etration of normal tissue by cancer cells [1]. Recent
advances have highlighted the importance of the acid com-
ponent of the tumour microenvironment in driving invasive
capacity and subsequent malignant progression [2-4]. The
activity of the Na+–H+ exchanger (NHE) isoform 1 is known
to play a role in acidifying the tumour microenvironment [5],
and the nutrient-deprived conditions that are common to
the tumour microenvironment activate tumour cell NHE1,
which in turn stimulates increased motility and invasive
capability [6]. This role played by Na+–H+ exchanger activ-
ity in driving tumour cell motility has been corroborated in
transformed renal cells [7,8] and in ascites hepatoma cells
[9], emphasizing the importance of understanding the
mechanisms that control Na+–H+ exchanger activity in
tumour cells.
The Rho family of small GTPases has been shown to play
a major role in regulating the rearrangement of the actin
cytoskeleton in response to cell stimulation [10] and to be
involved in the regulation of a variety of other cellular proc-
esses, such as organization of the microfilamental network,
cell–cell contact, motility and apoptosis [11]. Early studies
in fibroblasts suggested that Cdc42, Rac1 and RhoA are
organized in hierarchical cascades in which activated
Cdc42 activates Rac1, in turn activating RhoA [10]. It is
now known that these G-proteins can be organized in many
other ways. For example, Rac1 or Cdc42 have been shown
to oppose or modify RhoA action in the regulation of a
number of processes, including actin cytoskeleton remod-
elling [12], axon guidance [13], dendrite branching [14]
and cell migration [15-17]. Thus, it is clear that the interac-
tions and associations of the various members of the Rho
family are cell/tissue-specific or function-specific, or both.
Despite the evidence that Rho GTPases are overexpressed
in tumours [18] and play an important role in mitogenesis,
proliferation and invasiveness [19], our understanding of
how they interact among themselves in tumour cells to reg-
ulate these processes is still incomplete and represents an
important issue in oncology [20].
Molecular control of actin organization is probably at the
core of cell motility, and it is of importance that we gain an
understanding of the mechanisms that underlie the regula-
tion of actin dynamics so that we may appreciate how motil-
ity is regulated. Recent studies conducted in smooth
muscle cells have led to a model (for review see [21,22])
that associates RhoA with contraction via activation of Rho
kinase (ROCK) and ROCK-dependent phosphorylation of
myosin phosphatase, thereby inactivating it and resulting in
an increase in the phosphorylation state of myosin light
chain and enhancement of myosin binding to actin fila-
ments. Rac1 via activation of the p21-activated kinase
(PAK) antagonizes this process by blocking the activity of
myosin light chain kinase. As recently discussed [23], this
mechanism pertains to smooth muscle cell contraction and
cannot fully explain the effects of Rho family proteins on the
actin cytoskeleton in other cell types, such as epithelial
cells. Two other mechanisms have been described in which
Rac1 downregulates RhoA activity via a redox-dependent
mechanism [17] and by stimulating RhoA degradation via
Smurf1 [24]. Recently, however, a further possible cross-
regulatory mechanism has emerged. Pioneering studies in
fibroblasts have shown that NHE1, a regulator of intracellu-
lar pH (pHi), can play a direct role in controlling actin
dynamics and subsequent motility through a protein–pro-
tein interaction with the cytoskeletal adaptor protein ezrin,
and that, in those cells, RhoA-dependent modulation of
cytoskeletal dynamics and motility occurred via direct reg-
ulation of NHE1 activity [25,26]. There is increasing evi-
dence that activity of the NHE1 is essential for motility in
various cell types [6-9,26]. Accordingly, the questions are
whether RhoA and Rac1 reciprocally regulate motility in
tumour cells of epithelial origin, and if so then do they act
via a coordinated regulation of NHE1 activity?
We previously reported that serum deprivation, a common
component of the tumour microenvironmental, stimulates
NHE1 in human epithelial breast cancer cells and drives
increased cellular motility and invasive ability via the acti-
vated NHE1 [6]. In light of this essential role played by
NHE1 in regulating motility in these cells, the present study
was undertaken to characterize the role and pattern of reg-
ulation by Rho GTPases of this serum deprivation-depend-
ent activation of both NHE1 and subsequent basic invasive
characteristics, such as pseudopodia and invadiopodia
protrusion, directed cell motility and penetration of normal
tissues [27,28]. The study was conducted in a well charac-
terized human mammary epithelial cell line that represents
a late phase in metastatic progression, namely MDA-MB-
435 [6]. We observed that serum deprivation inhibits RhoA
activity and stimulates Rac1 activity and, using dominant
negative and constitutively active mutants, that Rac1 and
RhoA are antagonistic regulators of tumour cell NHE1
activity. As was observed in the regulation of this phenom-
enon by phosphoinositide-3 kinase (PI3K) [6], a reversal of
RhoA and Rac1 regulatory action on NHE1 activity found in
serum replete conditions was found during serum depriva-
tion-dependent upregulation of NHE1. Although serum
deprivation reversed the regulatory actions of Rac1 and
RhoA on NHE1 activity, the basic pattern of antagonism of
action between these two G-proteins was maintained. Fur-
thermore, the same pattern of RhoA and Rac1 regulation
found for NHE1 activity was observed in both basal and
serum deprivation-dependent increases in cell invasion and
motility. Together with the recent reports demonstrating the
direct role of NHE1 in controlling actin dynamics in fibrob-
lasts [25,26], our findings suggest that the reported antag-
onistic roles of RhoA and Rac1 in cell motility and
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concerted action on NHE1 activity as a convergence point.
Methods
Cells and construction of expression vectors containing 
RhoA mutants
MDA-MB-435 cells were cultured as previously described
[6]. Minus serum growth medium was complete Dulbeccos
modified Eagle's medium (DMEM; GibcoBRL, Milano, Italy)
without serum, in which the osmolarity, if necessary, had
been adjusted to be identical to the plus serum medium by
the addition of the necessary amount of mannitol. To
deprive cells of serum, monolayers that had grown to con-
fluency in complete DMEM with 10% foetal calf serum
were washed two times in the minus serum DMEM and
then the same volume of minus serum medium was added
and the monolayers replaced in the incubator. After the
indicated times the experiments were conducted.
pCEFL plasmids containing the dominant negative
N19RhoA, N17Rac1 and N17Cdc42 mutants were kindly
provided by Dr PP Di Fiore (European Institute of Oncol-
ogy, Milan, Italy) and pEXV plasmids containing the consti-
tutively active V14RhoA and V12Rac1 mutants by Dr MH
Symons (Picower Institute for Molecular Research, Man-
hasset, NY, USA). These cDNAs were subcloned into the
pBabe puro expression vector containing a haemagglutinin
(HA) tag. Ten micrograms of plasmid cDNA or empty vec-
tor was incubated with 100 µl LipoTaxi reagent (Strata-
gene, La Jolla, CA, USA) in 1 ml of simple DMEM growth
medium for 30 min at room temperature. Serum was added
to 3% and 200 µl of this mixture was pipetted onto conflu-
ent monolayers on glass coverslips and placed in an incu-
bator at 5% CO2 and 37°C for 6 hours. This mixture was
then replaced with fresh complete medium (10% serum)
for 24 hours in normal growth conditions. Cells were then
treated and NHE1 activity, motility, or invasion were meas-
ured. The level of transfection was determined using West-
ern blot of whole cell extracts using anti-HA antibody
(Santa Cruz, Santa Cruz, CA, USA). The percentage of
transfection with different concentrations of cDNA (0, 2.5,
5 and 10 µg plasmid cDNA) was evaluated by immunoflu-
orescence microscopy of cell monolayers on coverslips
using the same anti-HA antibody. As shown in Fig. 1 the
transfection efficiency for both the dominant negative (dn)
N17Rac1 cDNA and N19RhoA cDNA was commensurate
with cDNA concentration and reached approximately 90%
when cells were transfected with 10 µg plasmid cDNA. The
transfection efficiencies observed with the other cDNAs
utilized in the study were very similar to those for N19RhoA
and N17Rac1 (data not shown).
Intracellular pH and H+ efflux rate determinations
Intracellular, cytoplasmic pH (pHi) was measured spec-
trofluorimetrically at 37°C with the fluorescent pH sensitive
probe 2',7'-bis(carboxyethyl)-5, 6-carboxy-fluorescein
(BCECF), and trapped intracellularly in cell monolayers
grown on glass coverslips as previously described [6].
Figure 1
Efficiency of transfection with Rho family constructsi  f il  str ts. MDA-MB-435 cell 
monolayers were transfected with variable concentrations of the pBabe 
vector containing either the dominant negative (a) N17Rac1 or (b) 
17NCdc42 construct. Forty-eight hours later the monolayers were fixed 
with 4% paraformaldehyde, and the expression of the haemagglutinin 
(HA) tag visualized by immunofluorescent microscopy with an anti-HA 
antibody. The percentage of cells expressing HA-tagged N17Rac1 
increased in a concentration-dependent manner and reached approxi-
mately 90% when the cells were transfected with 10 µg plasmid cDNA.
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after an intracellular acid load produced with the NH4Cl
prepulse technique. The initial rate of Na+-dependent alka-
linization was determined by linear regression analysis of
the first 15 points taken at 4 s intervals after the readdition
of sodium. The use of CO2/HCO3 free solutions minimizes
the likelihood that Na+-dependent HCO3 transport was
responsible for the observed changes in pHi. The pHi
dependence of intracellular buffer capacity (βi; i.e. the buff-
ering power of all non-HCO3, non-CO2 buffers) was com-
puted using the NH4 pulse method, and the actual activity
of the exchanger in terms of proton flux rate (mmol/l H+/
min) was determined by multiplying the rates of pHi change
by the cells' intrinsic buffering capacity (βi) at the pHi at
which the measurement was taken. Preliminary experi-
ments demonstrated that 2 µmol/l of the specific NHE1
inhibitor 5-(N, N-dimethyl)-amiloride (DMA; Sigma, Milano,
Italy) almost completely blocked NHE1 activity, whereas
transfection with empty pBabe vector had no effect on
NHE1 activity (data not shown).
Motility and invasion
A quantitative measure of the degree of in vitro motility of
the cells was obtained in BW25 Boyden Chambers (Neuro
Probe Inc., Cabin John, MD, USA) using 8 µm polycar-
bonate membranes (Poretics, Livermore, CA, USA) coated
with 5 µg collagen I as previously described [6]. After 4
hours of incubation, cells were fixed and stained (DiffQuick;
Baxter, Oakland, CA, USA), those cells that had not trans-
versed the filter were removed, and randomly chosen fields
were photographed at 100× magnification using a Nikon
Eclipse E800 microscope equipped with an MRC-1024
imaging system (Bio-Rad Laboratories, Milano, Italy). The
number of cells traversing the filter in four random fields for
each filter were counted from these images.
A quantitative measure of the degree of in vitro invasion
was measured as the ability to infiltrate into live, confluent
MCF-10A monolayers, essentially as previously described
[6,29]. MDA-MB-435 cells were metabolically loaded with
3H-thymidine for the 24 hours prior to the experiment, cells
were trypsinized, and a standard curve of incorporated 3H-
dT/cell measured for each treatment. Tumour cells
(80,000) were added in suspension to the complete
medium of the confluent MCF-10A monolayers. Culture
dishes were returned to the incubator for 8 hours and then
unattached cells were removed by vigorous washing and
mechanical agitation two times with phosphate-buffered
saline (PBS). The number of MDA-MB-435 cells that had
invaded the MCF-10A monolayer was calculated by meas-
uring the incorporated 3H-thymidine for each MCF-10A
monolayer in a Packard TopCount NXT® microplate scintil-
lation counter (Packard Instruments, Inc., Palo Alto, CA,
USA), and the number of cells present computed using the
standard curve of disintegrations per min/cell for each
treatment. Experiments standardizing this assay against the
Boyden Chamber matrigel assay demonstrated high corre-
lation between the two techniques.
Expression and activity of RhoA and Rac1
RhoA and Rac1 activity were assessed using the RhoA-
binding domain of Rhotekin or Rac1-binding domain of
PAK-1, respectively, in kits supplied from Upstate Biotech-
nology (Lake Placid, NY, USA). In brief, 3 × 106 cells were
plated onto 10 cm cell culture dishes and after 24 hours
they were treated as indicated. After the indicated time,
cells were extracted using RIPA buffer (50 mmol/l Tris, pH
7.2, 500 mmol/l NaCl, 1% Triton X-100, 0.5% sodium
deoxycholate, 1% SDS, 10 mmol/l MgCl2, 0.5 µg/ml leu-
peptin, 0.7 µg/ml pepstatin, 4 µg/ml aprotinin, and 2 mmol/
l PMSF). After centrifugation at 14,000 g for 3 min, the
extracts were incubated for 45 min at 4°C with glutathione
beads coupled with glutathione S-transferase (GST)–RBD
(Rho-binding domain of Rhotekin) fusion protein or GST-
PAK-1 (Upstate Biotechnology), and then washed three
times with Tris buffer (pH 7.2), containing 1% Triton X-100,
150 mmol/l NaCl and 10 mmol/l MgCl2. The RhoA or Rac1
content in these samples or in 50 µg protein of cell
homogenate was determined by immunoblotting samples
using rabbit anti-RhoA antibody (Santa Cruz) or anti-Rac1
antibody (Upstate Biotechnology).
Fluorescence microscopy
For analysis of actin cytoskeleton organization, cells were
plated on coverslips until they were approximately 60%
confluent, at which time they were transfected with empty
vector or dn-RhoA or dn-Rac1 and, after 24 hours of incu-
bation, they were either subjected or not subjected to
serum starvation in the presence or absence of 2 µmol/l
DMA. After 24 hours, cells were fixed with 4% paraformal-
dehyde in PBS for 15 min, and after residual formaldehyde
had been quenched with 50 mmol/l NH4Cl in PBS for 10
min the cells were permeabilized with 0.2% Triton X-100 in
PBS for 10 min. Filamentous actin (F-actin) was stained
with fluorescein isothiocyanate-conjugated phalloidin
(Sigma) in PBS (0.5 U/ml) for 1 hour, whereas HA-positive
cells were determined with anti-HA antibody (Santa Cruz)
at a 1:100 dilution. Microscopy was performed using an
MRC-1024 imaging system (Bio-Rad Laboratories)
equipped with a Nikon Eclipse E800 microscope and a
Nikon Plan Apo 40-by-1.0 or 60-by-1.4 oil immersion
objective lens.
Analysis of F-actin content
Actin polymerization was detected using fluorescent phal-
loidin and analyzed by confocal microscopy and fluores-
cence activated cell sorting analysis. Analytic flow
cytometric measurements were performed basically as pre-
viously described [30], using a Hewlett-Packard 9153C
flow cytometer with argon laser excitation at 488 nm and
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thousand cells in each sample were analyzed. For determi-
nation of F-actin amount the gate was defined as corre-
sponding to scatter parameters on a dot plot of viable
control cells (nondeprived). Phalloidin–fluorescein isothio-
cyanate fluorescence intensities from the gated population
were presented as a histogram and the geometrical mean
value was used as a measure of F-actin content.
Kinetic and statistical analysis
The kinetic coefficients for proton dependency of exchange
activity were estimated using nonlinear curve-fitting regres-
sion utilizing the iterative Marquardt procedure on the
KALIDIOGRAPH® (Abelbeck Software, Reading, PA,
USA) program. The proton data were fitted to the Hill equa-
tion – V = (Vmax [H]n)/(Km + [H]n) – in which V is the exper-
imental transport velocity, Vmax is the calculated maximum
transport velocity, [H] is the cytosolic proton concentration,
Km is the apparent affinity for protons, and n is the apparent
Hill coefficient.
Results
NHE1 lies upstream of serum deprivation-dependent 
actin cytoskeletal reorganization
We previously showed that serum deprivation selectively
stimulates NHE1 activity in breast cancer cells and their
subsequent NHE1-dependent motility and invasion [6].
Recently, mounting evidence has shown that NHE1-
dependent regulation of motility in normal cells occurs by
direct NHE1-dependent reorganization of the actin
cytoskeleton [25,26]. To evaluate whether NHE1 is
upstream of actin reorganization during serum deprivation
in cancer cells, we followed the serum deprivation-depend-
ent remodelling of the F-actin cytoskeleton (Fig. 2a) and
quantity of F-actin (Fig. 2b,2c) in the presence or absence
of the specific NHE1 inhibitor DMA. As can be seen in Fig.
2a, control cells were primarily fusiform in shape with thin,
uniform, parallel actin filaments (stress fibres) departing
from single points and extending throughout the length of
the cell. Serum deprivation provoked a complex and dra-
matic reorganization of the actin cytoskeleton, resulting in a
reduction in the number of stress fibres with an uneven
thickening of the remaining stress fibres. Consistent with
the model proposed by the group of Barber [25,26], inhibi-
tion of NHE1 during serum deprivation with 2 µmol/l DMA
completely abrogated the observed serum deprivation-
dependent cytoskeletal reorganization, and depolymeriza-
tion suggesting that stimulation of NHE1 is indeed up-
stream of actin cytoskeletal reorganization. As can be seen
in Fig. 2c, treatment with the actin cytoskeleton disruptor
cytochalasin B (5 µmol/l for 15 min) reduced the amount of
F-actin by approximately 75%. The lack of significant inhib-
itory effect by cytochalasin B treatment on NHE1 activity
(absence versus presence of cytochalsin B: 16.2 ± 2.7 ver-
sus 20.6 ± 4.7 mmol/l intracellular H+ concentration/min
[27% increase], n = 7; P = 0.58) further supports this
hypothesis [31].
Serum deprivation activates Rac1 and inactivates RhoA
The usual model for RhoA-dependent alterations in motility
is linked to RhoA action upon the actin cytoskeleton via the
phosphorylation/inactivation of myosin phosphatase by the
RhoA effector p160ROCK [21,22]. However, mounting
evidence has suggested the existence of an alterative sys-
tem in which RhoA/ROCK directly alters NHE1 activity [32]
followed by the NHE1-dependent reorganization of the
actin cytoskeleton [25,26]. It was recently reported that the
tight junction protein NZO-3 increases kidney cell motility
via a decrease in stress fibre number due to an inhibition of
RhoA activity [33], and dihydromotuporamine C decreases
cancer cell motility and invasion via an increase in stress
fibre number that was due to a stimulation of Rho activity
[34].
As a starting point for our study of the regulatory pattern of
RhoA and Rac1 in the serum deprivation regulation of NHE
activity and the migration/invasion of MDA-MB-435 cells,
we measured the effect of serum deprivation on the activa-
tion status of RhoA and Rac1. To assess RhoA and Rac1
activation states, we used the GST fusion proteins of RBD
to capture GTP-bound RhoA, and PAK-1 Rac-binding
domain to capture GTP-bound Rac-1 from cell extracts. As
shown in Fig. 3, serum deprivation resulted in a significant
decrease in the amount of RhoA retained by RBD (panel a)
and in a significant increase in Rac1 retained by PAK-1
Rac-binding domain (panel b). In contrast, serum depriva-
tion had no effect on total cellular expression of either RhoA
or Rac-1, demonstrating that it is indeed changes in their
activity and not expression that drives their regulatory con-
trol of NHE activity. A similar pattern of inverse correlation
between levels of active RhoA and active Rac1 was previ-
ously described in epithelial cells and fibroblasts [35,36].
RhoA and Rac1 reciprocally regulate the activity of NHE1 
in basal and serum deprivation stimulated conditions
To address the question of whether Rho proteins are
involved in the regulation of tumour cell NHE1 activity, we
compared the effect of transient transfection of HA-tagged
dn (Fig. 4a) or constitutively active (ca; Fig. 4b) mutants of
Rho family proteins on both the basal activity of the NHE1
and its activation by serum deprivation. The relative level of
transfection was determined using Western blot of whole
cell extracts using anti-HA antibody (the inserts in the
respective bar graphs in Fig. 4). The transfection efficiency
for the various cDNAs was commensurate with cDNA con-
centration and reached approximately 90% when the cells
were transfected with 10 µg plasmid cDNA (see the Meth-
ods section, above).
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of NHE1 activity was regulated reciprocally by these
mutant constructs; specifically, NHE1 was slightly but sig-
nificantly stimulated by inactivation of Rac1 induced by
transfection with dn-N17Rac1 (stripped bar), and slightly
but significantly inhibited by inactivation of RhoA induced
by transfection with dn-N19RhoA (hatched bar). In serum
deprived conditions NHE1 activity was still regulated recip-
rocally but the role of these G-proteins was reversed; inac-
tivation of RhoA with N19RhoA potentiated the serum
deprivation-dependent stimulation of the NHE1 (hatched
bar), whereas inactivation of Rac1 with N17Rac1 blocked
this stimulation (stripped bar). Inactivation of Cdc42 with
dn-N17Cdc42 inhibited NHE1 activity to a similar degree
in both nondeprived and deprived conditions (stippled
bars).
These data suggest that RhoA and Rac1 play antagonistic
roles in the regulation of both basal and serum deprivation-
induced NHE1 activity, and that there is a reversal of their
regulatory action with serum deprivation. To confirm this
hypothesis, cells were transfected with constitutively active
mutants of RhoA and Rac1. Activating RhoA with
V14RhoA blocked serum deprivation-mediated stimulation
of the NHE1 whereas the constitutively active V12Rac1
potentiated NHE1 stimulation by serum deprivation (Fig.
4b). Treating the cells with either a RhoA-specific pharma-
cological inhibitor (C3 exotoxin) or activator (CNF-1) pro-
duced a pattern identical to that observed with the RhoA
mutated constructs (data not shown).
NHE1 activity is finely regulated by intracellular proton con-
centration via an allosteric proton regulatory site, and we
previously showed that serum deprivation upregulated
tumour cell NHE activity via an increased H+ affinity of this
Figure 2
Role of Na+–H+ exchanger (NHE)1 in serum deprivation-dependent rearrangement of the actin cytoskeleton
rearrangement of the actin cytoskeleton. (a) To examine the role of 
NHE1 in serum deprivation-induced reorganization of the actin 
cytoskeleton underlying motility and invasive ability, MDA-MB-435 cell 
monolayers were left in fresh whole growth medium (nondeprived [ND]) 
or were serum deprived (D) in the presence or absence of 2 µmol/l of 
the specific NHE1 inhibitor 5-(N, N-dimethyl)-amiloride (DMA) for 1 day. 
The fluorescent photomicrographs show cell groups at a magnification 
of 40× (bar = 10 µm). (b) typical one-parameter fluorescence distribu-
tions of MDA-MB-435 cells labelled with phalloidin–fluorescein isothio-
cyanate in the above experimental conditions. The lighter coloured 
curve is from control, ND cells. Cyt B is the fluorescence distribution 
after treatment with the actin cytoskeleton disruptor cytochalasin B (5 
µmol/l for 15 min). (c) Relative intracellular F-actin content measured by 
flow cytometry in MDA-MB-435 cells in the above experimental condi-
tions. Mean ± standard error. n = 9; **P < 0.001 versus ND cells.
Figure 3
Serum deprivation activates Rac1 and inactivates RhoA without changes in total cellular expression
changes in total cellular expression. MDA-MB-435 cells were nonde-
prived (t0) or deprived of serum for 6 or 24 hours and cell extracts were 
assayed for (a) Rhotekin or (b) p21-activated kinase (PAK-1)-binding 
activity, respectively, as described in the Methods section. Representa-
tive immunoblots from these experiments are shown. For these experi-
ments, the RhoA bound to the RBD or Rac1 bound to PAK-1 (upper 
panels) were normalized to the total RhoA or Rac1 content of cell 
extracts (lower panels). GST, glutathione-S-transferase; RBD, Rho-
binding domain of Rhotekin (upper panel) or Rac-binding domain (lower 
panel); WB, Western blot.
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intracellular H+ [6]. To determine whether RhoA and Rac1
modulate the serum deprivation-dependent upregulation of
the NHE1 via this same mechanism, we analyzed the effect
of the dominant negative mutants of RhoA or Rac1 on the
dependence of NHE1 activity on pHi in serum deprived
cells, as previously described [6]. Fig. 5 shows the relation-
ship of NHE1 activity (∆mmol/l intracellular H+ concentra-
tion/min) to pHi in 24 hr serum complete (open circles) and
serum deprived cells minus (closed circles) or plus trans-
fection with dn-N17Rac1 (squares) or dn-N19RhoA (trian-
gles) in a typical experiment. Serum deprivation shifted the
pK value for intracellular H+ to alkaline values (alkaline shift)
and increased the slope of the relationship. The observed
alkaline shift in serum deprived conditions in the tumour
cells is consistent with an increased capacity for net acid
extrusion. In the cells transfected with dn-N17Rac1
(squares) serum deprivation no longer had any significant
effect on the alkaline shift produced by serum deprivation,
whereas transfection with dn-N19RhoA potentiated this
alkaline shift. Kinetic analysis on five independent experi-
ments for each treatment demonstrated that the Vmax and
H+ affinity increased in MDA-MB-435 cells upon serum
deprivation (Table 1) without a change in the Hill coefficient
(napp remained approximately 2). Also, transfection with dn-
N17Rac1 blocked the serum deprivation-dependent
kinetic shifts whereas transfection with dn-N19RhoA
potentiated them. These data suggest that one of the
mechanisms by which RhoA and Rac1 regulate the serum
deprivation-dependent increases in NHE1 activity is by
modifying the affinity of the internal proton regulatory site of
the NHE1 for protons.
Figure 4
Effect of Rho family mutants on the basal and serum deprivation stimu-lation of Na+–H+ exchanger (NHE)1 activity
lation of Na+–H+ exchanger (NHE)1 activity. To determine the role of 
Rho family G-proteins in the regulation of basal and serum deprivation 
stimulated Na+–H+ exchanger (NHE)1 activity, monolayers were trans-
fected with empty pBabe vector or vector containing mutated Rho fam-
ily genes. After 24 hours, medium was replaced with either serum 
replete or deplete medium for an additional 24 hours. Intracellular pH 
recoveries were measured and the initial rate of the NHE1 activity cal-
culated as Na+-dependent H+ efflux, as described in the Methods sec-
tion. All measurements were conducted in nominally HCO3-free, 
HEPES-buffered solutions in order to measure only the NHE. (a) Effect 
of dominant negative (dn) Rho family mutants on the serum deprivation-
dependent upregulation of NHE1 activity. (b) Effect of constitutively 
active (ca) RhoA and Rac1 mutants on the serum deprivation-depend-
ent upregulation of NHE1 activity. Data for control cells are shown in 
the gray solid bars, whereas the stippled bars represent data for 
Cdc42, stripped bars represent data for Rac1 and hatched bars repre-
sent data for RhoA. Data are expressed as means ± standard error for 
between 9 and 20 observations in each condition. *P < 0.01, **P < 
0.001 versus control values; +P < 0.01, ++P < 0.001 versus deprived 
values. Insets show the level of transfection of haemagglutinin (HA)-
tagged cDNA in a typical experiment by Western blot of whole cell 
extracts using anti-HA antibody.
Figure 5
Effect of dominant negative (dn) RhoA and Rac1 mutants on the intrac-ellular (pHi) depend nce of net acid extrusion rate
ellular (pHi) dependence of net acid extrusion rate. To examine the 
mechanism of RhoA and Rac1 modification of the serum deprivation-
dependent increase in Na+–H+ exchanger (NHE)1 activity, the intracel-
lular pH (pHi) dependence of NHE1 activity (∆mmol/l H+ i/minute) in 
MDA-MB-435 cell monolayers was measured. Monolayers were left in 
fresh whole growth medium (open circles) or serum deprived (closed 
circles) plus dn-N19RhoA (triangles) or dn-N17Rac1 (squares) for 24 
hours. Results from a typical experiment are shown. The plots were 
computed as described in the Methods section. H+ i, intracellular pro-
ton concentration.
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deprivation-induced alterations in cell shape and actin 
organization
In order to determine the alterations in F-actin cytoskeletal
organization associated with the above changes in cell
shape, we next incubated the cells with tetramethylrhodam-
ine 5-isothiocyanate (TRITC)-labelled phalloidin in order to
stain F-actin in the different treatments. As can be seen in
Fig. 6a, control cells were primarily fusiform in shape with
thin, uniform, parallel actin filaments (stress fibres) depart-
ing from single points and extending throughout the length
of the cell, with the presence of lamellipodia (arrow), but
there were few dominant, elongated pseudopodia and few
actin containing, fine cell extensions (termed invadopodia
[37,38]). Serum deprivation provoked a complex and dra-
matic reorganization of the actin cytoskeleton that resulted
in a reduction in number of stress fibres and lamellipodia,
with an uneven thickening of the remaining stress fibres
and an increase in both dominant leading-edge pseudopo-
dia (arrowhead) observed at the ends of the cells and in
invadopodia (asterisk). Interestingly, transfection with
mutant constructs that increase either basal or deprivation-
stimulated NHE1 activity and motility (e.g. dn-Rac1, ca-
RhoA, dn-RhoA plus deprivation or ca-Rac1 plus depriva-
tion) greatly augmented all of the serum deprivation-
induced alterations in cell shape and actin organization.
There was an increase in invadopodia in all conditions such
as to produce a halo-like effect around the cell. Further-
more, in all conditions that increased NHE1 and motility,
except for dn-Rac1, there was increased length and com-
plexity of the pseudopodia that reached its maximum devel-
opment in the condition of dn-RhoA plus deprivation (see
also the larger magnification of the end of an elongated
dominant leading-edge pseudopodia; Fig. 6b). A densio-
metric analysis (AutoDeblur 9.1; AutoQuant Imaging, Inc.,
New York, NY, USA; data not shown) confirmed that F-
actin pixel density decreased with serum deprivation and in
those treatments that increased invasion and motility (dn-
Rac1, ca-RhoA, dn-RhoA plus deprivation or ca-Rac1 plus
deprivation).
RhoA and Rac1 reciprocally regulate directed motility 
and invasive capacity of MDA-MB-435 cells via the 
activity of NHE1
We previously demonstrated that NHE1 activity plays a fun-
damental role in motility and invasion in MDA-MB-435 cells
[6], and so we analyzed the ability of dominant negative and
constitutively active mutants of RhoA or Rac1 to modify the
serum deprivation-induced motility and invasive ability of
MDA-MB-435 cells. As differential apoptosis could affect
the outcome of these measurements, the effects of trans-
fection of these mutants of RhoA and Rac1 on apoptosis
were analyzed and we observed that neither 1 day of serum
deprivation nor transfection of any plasmid had any
significant effect on apoptosis in either basal or serum
deprived states (data not shown).
As shown in Fig. 7, 24 hours of serum deprivation (D) sig-
nificantly increased basal, non-serum-deprived (ND) MDA-
MB-435 cell motility, measured as their ability to cross a
collagen I layer in a Boyden Chamber (Fig. 7a,7b) and their
capacity to invade a confluent MCF-10A cell monolayer
(Fig. 7c,7d). This serum deprivation-dependent stimulation
of motility and invasion was strongly inhibited in the cells
transfected with either dn-N17Rac1 or ca-V14RhoA and
was potentiated in the cells transfected with dn-N19RhoA
or ca-V12Rac1. Furthermore, in non-serum-deprived condi-
tions (ND), the basal level of cellular motility was regulated
opposite to that observed during deprivation by these
mutant constructs. That is, motility was slightly but signifi-
cantly stimulated by transfection with either dn-N17Rac1
or ca-V14RhoA and slightly but significantly inhibited by
transfection with dn-N19RhoA or ca-V12Rac1 (values
expressed as cells traversed/filter [mean ± standard error
of the mean]: control 2148 ± 80, dn-Rac1 3456 ± 263, ca-
RhoA 3055 ± 104, dn-RhoA 1727 ± 94, ca-Rac1 1287 ±
55; n = 5 for each treatment).
Altogether, these data strongly suggest that regulation of
both motility and invasion closely followed regulation of
NHE1 activity. Furthermore, incubation with 2 µmol/l of the
specific NHE1 inhibitor DMA almost completely abrogated
both basal motility and invasion and their stimulation by
serum deprivation, and the potentiation by either dn-
Table 1
Effect of serum deprivation on the kinetic parameters of the allosteric proton regulatory site in human breast cell monolayers
Kinetic parameter ND D D + dn-RhoA D + dn-Rac1
Vmax 19.6 ± 0.75 26.2 ± 0.86* 31.3 ± 0.88† 21.6 ± 0.9
K' for H+ 0.150 ± 0.02 0.113 ± 0.05† 0.105 ± 0.07† 0.137 ± 0.023
napp 2.19 2.16 2.03 2.23
Values are expressed as mean ± standard error for Vmax (mmol/l H+/minute) and H+ apparent K' (µmol/l) measured at 135 mmol/l external 
sodium. The Hill coefficient (napp) was derived at 135 mmol/l external sodium. Confluent cell monolayers were either kept in serum complete 
medium (nondeprived [ND]) or were placed in serum free growth medium (D) minus or plus dominant negative (dn)-RhoA or dn-Rac1 for 24 hours 
prior to measurement of ∆H+. n = 5; *P < 0.01, †P < 0.001, versus ND.
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Role of RhoA and Rac1 in serum deprivation-dependent rearrangement of the actin cytoskeleton and cell shape. To examine the role of RhoA and 
Rac1 in serum deprivation-induced reorganization of the actin cytoskeleton underlying motility and invasive ability, MDA-MB-435 cell monolayers 
were (a) left in fresh whole growth medium (nondeprived) or were serum deprived (deprived) for 1 day after transfection with empty pBabe vector 
(Cont) or with dominant negative (dn)-N19RhoA, constitutively active (ca)-V14RhoA, dn-Rac1 or V12Rac1 inserted in the same vector (bar = 10 
µm). Arrows indicate the presence of lamellipodia whereas pseudopodia are indicated by arrowheads and invadopodia along the cell surface or at 
the end of an dominant leading edge pseudopodia are indicated by an asterist. (b) The complex actin organization of a long, dominant leading edge 
pseudopodia extension in a cell transfected with dn-RhoA and deprived of serum at a higher magnification (bar = 5 µm).
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observation [6] and the findings of others [7-9] that the
NHE1 plays a fundamental role in tumour cell motility and
invasion. Serum deprived cells that had traversed the colla-
gen coated filter also exhibited a more motile shape than
did the serum replete cells (Fig. 7a), and this increase was
potentiated in the cells transfected with dn-N19RhoA and
attenuated in cells transfected with dn-N17Rac1.
Discussion
Rho family GTPases are greatly overexpressed in breast
tumours [18] and RhoA is necessary for Ras-mediated
transformation [19] and metastatic spread [39]. This sug-
gests that these G-proteins play a critical role in neoplastic
progression, but the mechanistic basis of their action in
tumour cells is still not completely clear [20]. Here we dem-
onstrate that the Rho family of GTPases are involved in the
regulation of basal NHE1 activity and especially in the
Figure 7
Effect of dominant negative (dn) and constitutively active (ca) RhoA and Rac1 mutants on the Na+–H+ exchanger (NHE)1-dependent stimulationof cell motility, inv sive capacity and cell shape by serum deprivation
cell motility, invasive capacity and cell shape by serum deprivation. To examine the effect of RhoA and Rac1 on serum deprivation-induced motility 
and invasive ability of the cells, MDA-MB-435 cell monolayers were left in fresh whole growth medium (nondeprived [ND]) or were serum deprived 
(D) after having been transfected with dn or ca mutants of RhoA (stippled bars) or Rac1 (stripped bars), or empty vector (empty bars) for 1 day. (a) 
For motility, cells were then trypsinized, centrifuged and resuspended in serum-free medium with or without 2 µmol/l 5-(N, N-dimethyl)-amiloride 
(DMA). Cells (20,000) were added to the upper chamber of a Boyden Chamber, in which the lower chamber containing medium plus 1% serum was 
separated by a collagen I coated filter with 8 µm pores. After 4 hours of incubation, filters were removed, processed as described in the Methods 
section, and the cells that had traversed the filter were photomicrographed (20×). The bar is 10 µm. Circles are the 8 µm pores of of the filter. (b) As 
described in the Methods section, the number of cells that tranversed the collagen I coated filter were counted in photomicrographs taken at 100×. 
Values are expressed as mean ± standard error. n = 4; **P < 0.001 versus nondeprived cells. For invasion, cells were metabolically loaded with 3H-
thymidine for the 24 hours prior to the experiment, MDA-MB-435 cells were trypinsized, centrifuged and resuspended in serum-free medium, and 
30,000 cells were added to the confluent MCF-10A monolayer in each well of a 96 well culture plate. After 8 hours incubation, noninvaded cells 
were removed and (c) the monolayer was photographed at 10× or (d) the number of invaded cells determined as described in the Methods section 
by counting in a Packard TopCount NXT® microplate scintillation counter. Values are expressed as mean ± standard error. n = 16; **P < 0.001 ver-
sus nondeprived cells.
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regulation of both basal NHE1 activity and its upregulation
by serum deprivation are linked to a reciprocity of RhoA and
Rac1 action (Fig. 4a,4b). We propose that in these breast
tumour cells this reciprocal antagonism between RhoA and
Rac1 precisely coordinates the specificity and/or magni-
tude of the pathophysiological response of NHE1 to serum
deprivation, with concomitant increases in motility and inva-
sion and hence malignant progression [6].
The reciprocal antagonism between the actions of Rac1
and RhoA on breast cancer cell NHE1 activity, motility and
invasive capacity is identical to that reported for movement/
migration [21,22] and actin cytoskeleton remodelling
[12,40] in other cell systems. Recent evidence supports a
prominent role for NHE1 in coordinating motility [6-9] by
selectively regulating cytoskeletal events such as focal
adhesion assembly and turnover, cortical cytoskeleton
dynamics and tyrosine phosphorylation of focal adhesion
kinase, with consequent impaired recruitment and assem-
bly of integrins, paxillin and vinculin at focal contacts [41].
Importantly, it was recently demonstrated that NHE1 can
regulate these processes through direct interaction with
the ERM family cytoskeletal linker protein ezrin [25,26]. In
the present study we observed that elevated NHE1 activity
is upstream from serum deprivation-dependent actin
remodelling (Fig. 2) and the consequent increase in motility
and invasion (Fig. 6); furthermore, we found that RhoA and
Rac1 act on these processes through a modification of
NHE1 activity. This association of increased motility with a
decrease in stress fibre number driven by inhibition of RhoA
activity is similar to that recently reported for the tight junc-
tion protein NZO-3 in controlling renal cell motility [33], and
inhibition of motility and invasion by dihydromotuporamine
C [34] or by degradation of RhoA by Smurf1 in controlling
Mv1Lu cell motility [24], suggesting a common mechanism.
In the latter work RhoA degradation was observed primarily
in the cell protrusions, and we are currently determining
whether inhibition of RhoA by serum deprivation occurs
preferentially in the leading edge pseudopodia of the MDA-
MB-435 cells.
Altogether these studies strongly suggest that in our cell
system the reported antagonistic roles of RhoA and Rac1
in cytoskeletal organization, motility and invasion may also
be due to their concerted, convergent action on NHE1
activity. Thus, RhoA and Rac1 integrate cytoskeletal reor-
ganization, which is necessary to direct motility via protein–
protein interactions of the NHE1 with other focal adhesion
components, and thus they facilitate or inhibit downstream
signalling and/or cytoskeletal cascades.
What remains unclear is whether the RhoA-dependent and
Rac1-dependent regulation actin organization via NHE1
forms an integral part of the myosin light chain kinase/
myosin phosphatase cycle [21,22], or whether it is part of
an independent, parallel system that may cooperate to pro-
duce the characteristic integration of cell movement by
RhoA and Rac1 antagonism. As discussed previously [23],
this mechanism concerns smooth muscle cell contraction
and cannot fully explain the effects of Rho family proteins
on the actin cytoskeleton in other cell types, such as epithe-
lial derived tumour cells. The studies performed to date
focused on specific cell types and/or experimental
systems, and so it is difficult to determine whether these
two mechanisms coexist and to interpret possible interac-
tions between the RhoA/Rac1 modulation of motility via the
regulation of NHE1 activity [25,26] or via the myosin
phosphatase/myosin light chain kinase cycle [21,22]. Fur-
thermore, it will be necessary to determine whether the
redox-dependent downregulation of RhoA by Rac1 with
subsequent regulation of cytoskeletion and motility
described in HeLa cells [17] has NHE1 as a downstream
target. In this way we can begin to acquire an organized
view of how the actin cytoskeleton and associated process
of motility are regulated by the Rho family of GTPases, and
to gain further insights into the mechanisms that underlie
the variability of action of these GTPases on actin
structures.
Conclusion
The present study defines the roles of RhoA and Rac1 in
the regulation of Na+–H+ exchange, and consequently of
motility/invasion in tumour cells and in the stimulation of
these processes that is unique to tumour cells when con-
fronted with serum deprivation – a common environmental
condition in tumours. The regulation of both basal NHE1
activity and its upregulation by serum deprivation are linked
to a reciprocity of the actions of RhoA and Rac1. Interest-
ingly, the role of each of these G-proteins is reversed dur-
ing serum deprivation; basal NHE1 activity is regulated
positively by RhoA and negatively by Rac1, whereas RhoA
negatively and Rac1 positively directs the stimulation of
NHE1 during serum deprivation (Figs 4 and 5).
The findings presented here extend those of our earlier
studies documenting the effects of serum deprivation and
the role of PI3K on pH regulation, in which we postulated
that the observed inversion of PI3K regulatory action con-
tributes, in part, to the upregulation of the NHE1 by serum
deprivation in tumour cells [6]. That deprivation-induced
switch from positive to negative PI3K regulation may reflect
a shift in the coupling of active Rho GTPases to different
signalling pathways. We postulate that it is this inversion of
RhoA/Rac1 function, together with PI3K regulatory action,
that contributes, in part, to the upregulation of NHE1 by
serum deprivation in MDA-MB-435 cells, and hence to
increased invasion and malignant progression.
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function is not clear but growing evidence indicates that a
delicate balance between positive and negative actions of
a signal cascade can determine the specificity and/or mag-
nitude of a physiological or pathophysiological response. A
particularly important area in biology is the study of mecha-
nisms that underlie dynamic organization of signalling net-
works in response to specific cellular signals. In the
currently developing paradigm, it is becoming ever clearer
that specificity of response in signal transduction is
attained through the compartmentalization of signalling
proteins and effectors close to their activators, regulatory
elements and targets to ensure tight regulation and specif-
icity of action of signalling cascades [39]. The assembly of
these multimolecular complexes or modules at the cellular
site of action is accomplished by scaffolding proteins that
have the capacity, through simultaneous interaction with
multiple signalling proteins, to integrate diverse signalling
pathways [40]. A possibility is that serum deprivation alters
the balance of expression or activity of a scaffolding pro-
tein, resulting in the creation of new spatiotemporal combi-
nations and/or altered integration of signal components.
Finally, the reversal in the roles of Rac1 and RhoA in the
regulation of NHE1 activity and motility observed here
might explain some seemingly contradictory reports in
which activating RhoA can lead to either increased or
decreased motility and invasiveness [18]. These discrepan-
cies possibly reflect different serum treatments of the
tumour cells after RhoA activation and point out the peril of
an across-the-board inhibition of RhoA as a possible ther-
apy. Importantly, these results also unify recent advances
concerning the mechanisms underlying tumour invasive
potential: the RhoA-ROCK activation of NHE1 [41,42], the
RhoA-ROCK mediation of invasion [43,44] and role of the
NHE1 in driving tumour cell motility [6-9] and invasion [6].
Further studies are now needed to elucidate the signal
transduction components that lie upstream and down-
stream of RhoA and Rac1 action, and to clarify the interac-
tions between the RhoA-and Rac1-dependent signal
transduction pathways that are involved in their reciprocal
antagonism. It will be of key interest to investigate the inter-
relationships between these activities and to define the
effectors and downstream mediators that are involved in
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